Abdel-Laetif MM, O’Riordan J, Windle HJ (2004)
NF-κB activation in esophageal adenocarcinoma: relationship to Barrett’ metaplasia, survival and response to neoadjuvant chemoradiotherapy.
Ann Surg 2004;239:491-500.
Agarwal SK, Chatterji A, Bhambhani S, Sharma BK. (1998)
Immunohistochemical co-expression of human papillomavirus type 16/18 transforming (E6) oncoprotein and p53 tumour supressor gene proteins in oesophageal cancer.
Indian J Exp Biol 1998;36:559-63.
Aiko S, Oshizumi Y, Ishizuka T, Sakano T, Kumano I, Sugiura Y, Maehara T. (2007) Reduction rate of lymph node metastasis as a significant prognostic factor in esophageal cancer patients treated with neoadjuvant chemoradiation terapy.
Dis Esophagus 2007;20:94-101.
Akamatsu M, Matsumoto T, Oka K. (2003)
C-erb2 oncoprotein expression related to chemoradioresistance in esophagus squamous cell carcinoma.
Int J Radiat Oncol Biol Phys 2003;57:1323-1327.
Akutsu N, Shirasawa H, Nakano K, Tanzawa H, Asano T. (1995)
Pare association of human papillomavirus DNA with esophageal cancer in Japan.
J Infect Dis 1995;171:425-8.
Altenahr E (1981)
Pathologische Anatomie, Ausbreitung und Metastasierung des Ösophaguskarzinoms In: Haring R, (Hrsg), Chirurgie des Ösophaguskarzinoms
Edition medizin, Weinheim 1981, S.17-28
Altorki N, Kent M, Ferrara RN. (2002)
Three-feld lymph node dissection for squamous cell and adenocarcinoma of the esophagus.
Ann Surg 2002;236:177-183.
Ancona E, Ruol A, Santi S (2001).
Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long-term survival of patients respectable esophageal squamous cell carcinoma: final report of a randomized trial of preoperative chemotherapy versus surgery alone.
Cancer 2001;91:2165-2174.
Ancona E, Cagol M, Epifani M, Cavallin F, Zaninotto G, Castoro C, Roul A. (2006) Surgical complications do not affect londterm survival after esophagectomy for carcinoma of the thoracic esophagus and cardia.
J Am Coll Surg 2006;203:661-669.
Arany I, Rady P, Tyring SK. (1995)
Effect on interferon therapy on human papillomavirus copy number in patients with Condyloma acuminatum.
Am J Med Sci 1995,310(1):14-8.
Arnott SJ, Duncan W, Gignoux M. (1998)
Preoperative radiotherapy in espohageal carcinoma: A meta-analysis using individual patient data (Oesophageal cancer Collaborative Group)
Int J radiat Oncol Biol Phys 1998;41: 579-583.
Asano M, Yukita A, Matsumoto T, Kondo S, Suzuki H. (1995)
Inhibition of tumour growth and metastasis by an immunizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121.
Cancer Res 1995,55:5296-5301.
Asworth MT, McDicken IW, Southern SA, Nash JRG. (1993)
Human papillomavirus in squamous cell carcinoma of the oesohagus associated with tylosis.
J Clin Pathol 1993;46:573-5.
Barbour AP, Rizk NP, Gerdes H, Bains MS, Rusch VW, Brennan, Coit DG.(2007)
Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction.
J Am Coll Surg 2007;205:593-601.
Barch DH, Fox CC. (1987)
Dietary zinc deficiency increases the metyhylbensylnitrosamine-induced formation of O6-methylguanine in esophageal DNA of the rat.
Carcinogen 1987,8:1461-4
Bartels H, Stein HJ, Siewert JR. (1998)
Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer.
Br J Surg 1998;85:840-844.
Benamouzig R, Pigot F, Quiroga G, Dalidire P, Chaussade S. (1992)
Human papillomavirus infection in esophageal squamous-cell carcinoma in Western countries.
Int J Cancer 1992;50:549-52.
Benamouzig R, Jullian E, Chang F, Robaskiewicz M, Flejou JF. (1995)
Absence of human papillomavirus DNA detected by polymerase chain reaction in French patients with esophageal carcinoma.
Gastroenterology 1995;109:1876-81.
Benulic T, Jancar B. (1995)
Treatment of advanced esophageal cancer by means of irradiation, cisplatinum and 5- fluoruracil.
Neoplasma 1995;42:141-5.
Berger C, Felix-Faure C, Chauvet B, Vincent P, Alfonsi M, et al. (1999)
Conservative treatment of anal canal carcinoma with external radiotherapy and interstinal brachytherapy, with or without chemotherapy: long term results.
Cancer Radiotherapy 1999,3(6):461-7.
Bhansali MS, Vaidya JS, Bhatt RG, Patil PK, Badwe RA, Desai PB. (1996)
Chamotherapy for carcinoma of the esophagus: a comparison of evidence from meta- analyses of randomized trials and of historical control studies.
Ann Oncol 1996;7:355-359
Bognár G, Ledniczky Gy, István G, Ondrejka P. (2006)
A colorectalis adenocarcinomák áttétképzésének molekuláris alapjai.
Magyar Sebészet 2006;59:342-350.
Bokelmann D. (1981)
Atiologie und Epidemiologie des Ösophaguskarzinoms.
In: Haring R. (Hrsg), Chirurgie des Ösophaguskarzinoms.
Edition medizin, Weinheim 1981, S.1-8-
Böhle AS, Kalthoff H. (1999)
Molecular mechanisms of tumor metastasis and angiogenesis.
Langenbeck’s Arch Surg 1999;384:133-140.
Brucher BL, Stein HJ, Zimmerman F. (2004)
Responders benefit from neoadjuvant radio-chemotherapy esophageal squamous cell carcinoma: results of a prospective phase–II trial.
Eur Surg Oncol 2004;30:963-971.
Bruzzi JF, Munden RF, Troung MT, Marom EM, Sabloff BS, Gladish GW, Iyer RB, Pan TS, Macapinlac HA, Erasmus JJ. (2007)
PET/CT of esophagea cancer: its role in clinical management.
Radiografics 2007;27:1635-1652.
Burmeister BH, Smithers BM, Gebski V. (2005)
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesphagus: a randomized contolled phase III trial.
Lancet Oncol 2005;6:659-668.
Castillo A, Aguayo F, Koriyama Ch, Torres M, Carrascal E, Naquira C, Palma M, Backhouse C, Argandona J, Itok T, Akiba S. (2006)
Human papillomavirus in esophageal squamous cell carcinoma in Columbia and Chile.
World J Gastroenterol 2006;14:6188-6192.
Ceresoli GL, Ferreri AJ, Cordio S, Villa E. (1998)
Role of dose intensity in conservative treatment of anal canal carcinoma. Report of 35 cases.
Oncology 1998,55(6):525-32.
Cooper K, Haffajee Z, Taylor L. (1999)
Bcl-2 immunoreactivity, human papillomavirus DNA and cervical intraepithelial neoplasia.
Modern Patology 1999,12(6):612-7.
Correa P. (1982)
Precursors of gastric and esophageal cancer.
Cancer 1982,50:254-65
Chang F, Shen Q, Zhou J, Wang C, Wang D, Syrjänen S. (1990)
Detection of human papillomavirus DNA in cytologic specimens derived from esophageal precancer lesions and cancer.
Scand J Gastroenterol 1990;25:383-8.
Chang F, Syrjänen S, Shen Q, Ji HX, Syrjänen K. (1990)
Human papillomavirus ( HPV ) DNA in esophageal precancer lesions and squamous cell carcinoma from China.
Int J Cancer 1990;45:21-5.
Chang F, Syrjänen S, Wang L, Syrjänen K. (1992) Infectiosus agents in the ethiology of esophageal cancer.
Gastroenterology 1992;103:1136-48.
Chang F, Syrjänen S, Shen Q, Wang L, Syrjänen K. (1993)
Screening for human papillomavirus inferctions in esophageal squamous cell carcinomas by in situ hybridisation.
Cancer 1993;72:2525-30.
Chen B, Yin H, Dhurandhar N. (1994)
Detection of human papillomavirus DNA in esophageal squamous cell carcinomas by the polymerase chain reaction using general consensus primers.
Human Pathol 1994;25:920-3.
Chidel MA, Rice TW, Adelstein DJ, Kupelian PA, Suh JH, Becker M. (1999)
Resecable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy.
Radiology 1999;213:67-72.
Chireac LR, Swisher SG, Ajani JA. (2005)
Post-therapy pathologic predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation.
Cancer 2005;103:11347-11355.
Conroy T, Kaminsky MC, Peiffert D, Wolff P. (2000) Non-surgical tratments of esophageal cancers.
Rev Med Int 2000;21;58-73.
Cooper K, Zaylor L, Govind S. (1995)
Human papillomavirus DNA in oesophageal carcinomas in South Africa.
J Pathol 1995;175:273-7.
Craddock VM. (1987)
Effect of the trichothecene mycotoxin diacetoxyscirpenol on nitrosamine-induced esophageal cancer and on relevant enzymes in esophagus and liver.
IARC Sci Publ 1987,84:266-269.
Crellin A. (2006)
Radiotherapy and chemotherapy in treatment of oesophageal and gastric cancer.
in Oesophagogastric surgery, ed.: Griffin SM, Raimes S., Elselvier Limited, Philadelphia, USA. 2006; p.194.
Daly Jm, Karnall LH, Menck HR. (1996)
National cancer data base report on esophageal carcinoma . Cancer 1996;78:1820-8.
Day NE. (1975)
Some aspects of the epidemiology of esophageal cancer.
Cancer Res 1975;35:3304-7.
Duong C, Greenawalt DM, Kowalczyk A, Ciavarella ML, Raskutti G, Murray WK, Phillips WA, Thomas RJ. (2007)
Pretreatmentgene expression profiles can be used to predict response to neoadjuvant chemotherapy in esophageal cancer.
Ann Surg Oncol 2007;14:3602-3609.
de Villiers EM. (1997)
Papillomavirus and HPV typing.
Clin Dermatol 1997;15:199-206.
de Villiers EM, Lavergne D, Chang F, Syrjänen K, Tosi P. (1999)
An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China.
Int J Cancer 1999;57:3989-92.
Dillner J, Knekt P, Schiller JT, Hakulinen T. (1995)
Prospective seroepidemological evidence that human papillomavirus type 16 infection is risk factor for esophageal squamous cell carcinoma.
Br Med J 1995;311:1346
Donington JS, Miller DL, Allen MS. (2003)
Tumor response to induction chemoradiation: influence on survival after esophagectomy.
Eur J CardioThorac Surg 2003;24:631-637.
Dürst M, Croce CM, Gissman L, Schwarz En Huebner K. (1987)
Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas.
Proc Natl Acad Sci 1987;84:1070-4.
Enzinger PC, Mayer RJ (2003) Esophageal cance.r
N Engl J Med 2003;349:2241-2252
Evander M, Frazer IH, Payne E, Qi YM, Hengst K, McMillan NA. (1997)
Indentification of the alpha6 integrin as a candidate receptor for papillomaviruses.
J Vir 1997,71(3):2449-56.
Fidalgo PO, Cravo ML, Chaves PP, Leitao CN, Mira FC. (1995)
High prevalence of human papillomavirus in squamous cell carcinoma and matched normal esophageal mucosa : assessment by polymerase chain reaction.
Cancer 1995;76:1522-8.
Fiorica F, DiBona D, Schepis F. (2004)
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta- analysis.
Gut 2004;53:925-930.
Fontanini G, Boldrini L, Vignati S, Chine S, Basolo S, Silvestri V. (1998)
Bcl-2 and p53 regulate vascular endothelial growth factor (VEGF) -mediated angiogenesis in non-small cell lung carcinoma.
Eur J cancer 1998;34:718-23.
Franceschi S, Munoz N, Bosch XF, Snijders PJ, Walboomers JM. (1996)
Human papillomavirus and cancers uf the upper aerodigestiv tract : a review of epidemiological and experimental evidence.
Cancer Epidemiology, Biomarkers & Prevention 1996;5:567-75.
Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer Cj. (1998)
Benign anal laesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and -negative anal carcinoma.
Br J Cancer 1998,78(11):1534-8.
Furihata M, Ohtsuki Y, Ogoshi S, Takahashi A, Tamiya T, Ogata T. (1993)
Prognostic significance of human papillomavirus genomes ( type -16, - 18 ) and abberant expresion of p53 protein in human esophageal cancer.
Int J Cancer 1993;54:226-30.
Gaca JG, Petersen RP, Peterson BL, Harpole DH. (2006)
Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma.
Ann Surg Oncol 2006;13:340-346.
Geh J, Crellin AM, Glynne-Jones R. (2001)
Preoperative (neoadjuvant) chemotherapy in oesphageal cancer.
Br J Surg 2001;88:338-356.
Gepski V., Burmeister B., Smithers BM., Foo K., Zalcberg J., Simes J., Australasian Gastro-Intestinal Trials Groop (2007)
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal cancer: a meta-analysis.
Lancet Oncol 2007; 8:226-234
Gerard JP, Morignat E, Romestaing P, Mornex F, Ardiet JM. (1998)
Radiotherapy of cancer of the anal canal. 15 years experience at the Lyon civil hospices and brief review of the literature.
Annales de Chirurgie 1998,52(1):17-23.
Gignoux M, Roussel A, Paillot B. (1987)
The value of preoperatíve radiotherapy in esophageal cancer: results oft he EORTC.
World J Surg 1987;11:426-432.
Gravit PE, Manos MM. (1992)
Polymerase chain reaction - based methods for the detection of human papillomavirus DNA . In : The epidemiology of cervical cancer and human papillomavirus. Eds.:
Munoz N, Bosch FX, Shah KV, Meheus A.
IARC Scientific Publications , Lyon 1992;121-133.
Green FL, Page DL, Fleming ID. eds. American Joint Committee on Cancer: AJCC Cancer Staging Manual, 6th Ed. New York, Springer Verlag. 2002.
Greer SE, Goodney PP, Sutton JE, Birkmeyer JD
Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis.
Surgery 2005;137:172-177.
Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z, Komaki RR, Rashid A, Hamilton SR, Wu TT. (2006)
The number of lymph nodes with metastasis pr5edicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
Cancer 2006;106:1017-1025.
Hagymási K, Tulassay Zs. (2007)
A nyelőcsőlaphámrák genetikai és molekuláris háttere és a génterápia lehetőségei.
Orv Hetil 2007;148:1795-1800.
Hale MJ, Liptz TR, Paterson AC. (1989)
Association between human papillomavirus and carcinoma of the esophagus in South African black.
S Afr Med J 1989;76:329-30.
Harnish DG, Belland LM, Scheid E, Rohan TE. (1999)
Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaktion.
Mol & Cell Probes 1999;13:9-21.
Havre PA, Yuan J, Hedrick L, Cho KR, Glazer PM. (1995)
p53 inactivation by HPV 16 E6 results in increased mutagenesis in human cells.
Cancer Res 1995;55:4420-4.
He D, Zhang DK, Lam KY, Ma L, Ngan HY, Liu SS. (1997)
Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation.
Int J Cancer 1997;72:959-64.
Higgins GD, Davy M, Roder D, Uzelin DM, Phillipps GE, Burell CJ. (1991)
Increased age and mortality associated with cervical carcinomas negative for human papilloma-virus DNA.
Lancet 1991;338:910-13.
Hille JJ, Margolius KA, Markowitz S, Isaacson C. (1986)
Human papillomavirus infection related to esophageal carcinoma in black South Africans.
S Afr Med J 1986;69:417-20.
Hoffmann L, Heher W. (1983) R123
Die Plattenepithelkarzinome der Mundhöhle Dtsch Med Wochenschr 1983,108:1150-2.
Holash J, Masonpierre PC, Compton D, Boland P, Alexander CR. (1999)
Vessel cooption , regression and growth in tumors mediated by angiopoietins and VEGF.
Science 1999;284:1994-8.
Holscher AH, Bollschweider E, Shneider PM. (1995)
Prognosis of early esophageal cancer: Comparison between adeno- and squamous cell carcinoma.
Cancer 1995;76:178-186.
Hording M, Hording U, Daugaard S, Norrild B, Faber V. (1989)
Human papilloma virus type 11 in a fatal case of esophageal and bronchial papillomatosis.
Scand J Infect Dis 1989;21:229-31.
Horváth ÖP, Cseke L, Kalmár K, Varga G, Horváth G. (2001)
Laringx preserving pharingo-esophagectomy after chemoradiation in the treatment of cancer of the pharingo-esophageal junction.
Ann Thor Surg (2001)72:2146-2147.
Hritz I, Herszényi L, Lakatos G, Prónai L,Tulassay Zs.(2006)
A nyelőcső rosszindulatú daganatai: kóreredet, diagnosis és kezelés: áttekintő tanulmány.
Orvosképzés 2006;81:11-20.
Huang CC, Kashima ML, Chen H, Shih IM, Kurman RJ, Wu TC. (1999)
HPV in situ hybridisation with catalysed signal amplification and polymerase chain reakction in establishing cerebellar metastasis of cervical carcinoma.
Hum Pathol 1999;30:587-91.
Ide H, Nakamura T, Hayashi K. (1994) Esophageal squamous cell carcinoma.
World J Surg 1994;18:321-30.
Ikeda G, Isai S, Chandra B, Watanabe M, Kawarada Y. (1999)
Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus.
Cancer 1999;86:1396-1405.
Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, et al. (1994) Prognostic significance of angiogenesis in human pancreatic cancer.
Br J Cancer 1999;79:1553-63.
Ikenberg H, Sauerbrei W, Schottmüller U, Spitz C, Pfleiderer A. (1994)
Human papillomavirus DNA in cervical carcinoma - correlation with clinical data and influence on prognosis.
Int J Cancer 1994;59:322-326.
Imdahl A, Bognar G, Schulte-Monting G, Schoffel U, fartmann EH, Ihling C. (2002) Predictive factors for response to neoadjuvant therapy in patients with oesophageal cancer.
Eur Cardio-Thorac Surg 2002;21:657-663.
Inoune K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S. (1997)
Vascular endothelial growth factor expression in primary esopageal squamous cell carcinoma. Association with angiogenesis and tumor progression.
Cancer 1997;79:206-213.
Isenberg G, Chak A, Canto MI, Levitan N, Clayman J, Pollack BJ. (1998)
Endoscopic ultrasounbd in restaging of esophageal cancer after neoadjuvant chemoradiation.
Gastrointestinal Endoscopy 1998;48:158-63.
Ishigami SI, Arii S, Furutani M, Niwano M, Harada T, Mizumoto M. (1998)
Predictive value of the vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer.
Br J Cancer 1998;78:1379-1384.
Jacquemier JD, Penault-Llorca FM, Bertucci F, Sun ZZ, Houvenaeghel GF. (1998) Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy : a multiparametric and immunohistochemical analysis
J Pathol 1998;184:130-5.
Jaskiewicz K, Marasas WFO, Van der Walt FE. (1987)
Oesophageal and other main cancer patterns in four districts of Transkei,1981-1984.
South Afr Med 1987;72:27.30.
Kajiyama Y, Hattori K, Tomita N, Amano T, Iwanuma Y, Narumi K, Udagawa H, Tsurumaru M. (2002)
Histopathologic effects of neoadjuvant therapies for advancede squamous cell carcinoma of the esophagus: multiple analysis of predictive factors and p53 overexpression.
Dis Esophagus 2002;15:61-66.
Kaklamanos IG, Walker GR,, Ferry K., Franceschi D, Livingstone AS. (2003)
Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis randomized clinical trials.
Ann Surg Oncol 2003;10:754-761
Kang SM, Maeda K, Chung YS. (1997)
Prognostoc value of vascular endothelial growth factor expression correlates with hematogenous metastasis and prognosis in colorectal carcinoma.
Cancer Res 1997,57:221-4.
Kato H, Tachimori Y, Watanabe H. (1993)
Evaluation of the new (1987) TNM classification for thoracic oesophageal tumors.
Int J Cancer 1993;53:220-23.
Katoh O, Takahashi T, Oguri T, Kuramoto K, Kobayashi M. (1998)
Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor.
Cancer Res 1998;58:5565-9.
Kelsen D. (1995)
Adjuvant therapy of upper gastrointestinal tract cancers.
Semin Oncol 1995;22:582-599.
Kelsen D., Ginsberg R., Pajak TF, Seahan DG., Gunderson L., Mortimer J., Estes N., Haller DG., Ajani J., Kocha W., Minsky BD., Throth JA. (1998)
Chemotherapy followed by surgery compaired with surgery alone localised esophageal cancel.
N Engl J Med 1998; 339:1979-1984
Kelsen D. (2001)
Preoperative chemoradiotherapy for esophageal cancer.
J Clin Oncol 2001,19:283-5.
Kelsen D, Winter K, Gunderson L, Mortimer J, Estes NC, Haller D, Ajani JA, Kocha W, Minsky Bd, Roth JA, Willett CG, Radiation Therapy Oncology Group. (2007) Long-term results of RTOG tral 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed surgery compared with surgery alone for esophageal cancer.
J Clin Oncol 2007;25:3719-3725.
Kentner GG, Cornelisse CJ, Jiwa NM, Aartsen EJ.65. Mooi W. (1993)
Human papillomavirus type 16 in tumor tissue of low-stage squamous cell carcinoma of the uterine cervix in relation to ploidy and prognosis.
Cancer 1993;71:397-401.
Kim WH, Song SY, Kang JK, Park IS, Choi HJ. (1991)
Detection of human papillomavirus DNA from esophageal cancer tissue using the polymerase chain reaction
Gastroenterology 1991;100A:1272
Kirby KS. (1960)
Induction of tumors by tannin extracts Br J Cancer 1960,14:147-50.
Kitagawa Y, Ueda M, Ando N, Ozagawa S, Takeuchi H, Kitajima M. (1998)
Prognostic factors of esophageal cancer Gan to Kagaku Ryoho 1998;25:2011-20.
Kitamura K, Saeki H, Kawaguchi H, Araki K, Ohno S, Kuwano H. (2000)
Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict sensitivity to neoadjuvant therapy in patients with esophageal cancer.
Hepato-Gastroent 2000,47(32):419-23.
Kiyabu MT, Shibata D, Arnheim N, Martin WJ, Fitzgibbons PL. (1989)
Detection of human papillomavirus in formalin-fixed , invasive squamous carcinomas using the polymerase chain reakction.
Am J Surg Pathol 1989;13:221-4.
Kleespies A, Guba M,Jjauch KW, Bruns CJ. (2004) Vascular endothelial growth factor in esophageal cancer.
J Surg Oncol 2004;87:95-104.
Kmet J, Mahboubi E. (1972)
Esophageal cancer in the Caspian littoral of Iran, initial studies.
Science 1972;175:846-53.
Kok TC, Nooter K, Tjong-A-Hung SP, Smits HL, Ter-Schegget JT. (1997)
No evidence of known types of human papillomavirus in squamous cell cancer of the oesophagus in low-risk area. Rotterdam Oesophageal Tumour Study Group.
Cancer 1997;33:1865-8.
Kulke MH, Odze RD, Mueller JD, Wang H, Redstone M, Bertagnolli MM. (2004) Prognostic significance of vascular endothelial growth factor and cyclooxigenase 2 expression in patients receiving preoperative chmemoradiation for esophageal cancer.
J Thorac CardioVasc Surg 2004;127:1579-1586.
Kulski J, Demeter T, Sterret GF, Shilkin KB. (1986)
Human papillomavirus DNA in esophageal carcioma.
Lancet 1986;2:683-4.
Kulski JK, Demeter T, Mutavdzic S, Sterret GF, Mitchell KM, Pixley EC. (1990)
Survey of hystologic specimens of human cancer for human papillomavirus types 6/11/16/18 by filter in situ hybridisation.
Am J Clin Pathol 1990;94:566-70.
Lam KY, He D, Ma L, Zhang D, Ngan NY, Wan TS. (1997)
Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese ang ist relationship with p53 gene mutation.
Hum Pathol 1997;28:657-63.
Laterza E, de’Manzoni G, Tedesco P, Guglielmi A, Verlato G, Cordiano C. (1999) Induction chemo-radiotherapy for squamous cell carcinoma of the thoracic esophagus:
long term results of phase II study.
Ann Surg Oncol 1999;6:777-84.
Lavergne D, de Villiers EM. (1999)
Papillomavirus in esophageal papillomas and carcinomas.
Int J Cancer 1999;80:681-4.
Law S, Kwong DL, Wong KH, Kwok KF, Wong J. (2006)
The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer.
J Gastrointest Surg 2006;10:1301-1311.
Le Buanec H, D’Anna R, Lachgar A, Zagury JF, Berard J, Ittele D. (1999)
HPV-16 E7 but not E6 oncogenetic protein triggers both cellular immunospuuression and angiogenic processes.
Biomed Pharmacother 1999;53:424-31.
Lehmann U, Bock O,Glockner S, Kreipe H.(2002)
Quantitative molecular analysis of laser microdissected paraffin-embedded human tissues.
Pathobiology 2000;68:202-208.
Lesec G, Gogusev J, Fermaud H, Gorce D, Lemaitre J-P, Verdier A. (1985) Presence of papilloma group viral antigen in an esophageal condyloma in man.
Gastroenterol Clin Biol 1985;9:166-8.
Lewensohn-Fuchs I, Munck-Wikland E, Berke Z, Magnusson KP. (1994)
Involvement of aberrant p53 expression and human papillomavirus in carcinoma of the head, neck and esophagus.
Anticancer Res 1994;14:1281-5.
Li J, Zhang Y, Gao D. (1996)
Study on the interrelationship between human papilloma virus infection and Langerhans cell in carcinogenesis of esophagus.
Chin J Path 1996;25:83-5.
Li JY, Ershow AG, Chen ZJ, Wacholder S, Li GY, Gou W, Li B. (1989) A case-controll study of cancer of the esophagus and gastric cardia in Linxian.
Int J Cancer 1989;43:755-761.
Loke SL, Ma L, Wong M, Srivastava G, Lo I, Bird CC. (1990) Human papillomavirus in esophageal squamous cell carcinoma.
J Clin Pathol 1990;43:909-12.
Lu JB, Yang WX, Liu JM, Li YS, Qin YM. (1985)
Trends in morbidity and mortality for esophageal cancer in Linxian country.
Int J Cancer 1985;36:643-645.
Lu SH, Ruggero M, Zhang MS, Feng L, Luo FJ, Chui SX, Diena U. (1986) Relevance of N-nitrosamines to esophageal cancer in China.
J Cel Physiol 1986;4:51-58.
Lu Y, Zhang Z, Liu Q, Liu B, Song X, Wang M, Zhao X, Zhao Q.(2007)
Immunological protection against HPV16 E7 expressing human esophageal cancer cell challenge by a novel HPV16-E6/E7 fusion protein based-vaccine in a Hu-PBL-SCID mouse model.
Biol Pharm Bull 2007;30(1):150-156.
Macadam R, Sarela A, Wilson J. (2003)
Bone marrow micrometastasis predict early postoperative recurrence following surgical resection of oesophageal and gastric carcinoma.
Eurg J Surg Oncol 2003;29:450-454.
MacGuill M, Mulligan E, Ravi N, Rowley S. (2006)
Clinicopathologic factors predicting complete pathological response to neoadjuvant chemotherapy in esophageal cancer.
Dis Esophagus 2006;19:273-276.
Maeda K, Kang SM, Onoda N, Ogawa M, Sawada T, Nakata B. (1998)
Expression of p53 and vascular endothelial growth factor associated with tumor angiogenesis and prognosis in gastric cancer.
Oncology 1998;55:594-9.
Mahboubi EO, Kmet J, Cook PJ, Day NE, Ghadman P, Salmasizateh S. (1973)
Oesophageal cancer studies in the Caspian littoral of Iran : the Caspian cancer registry.
Br J Cancer 1973;28:197-214.
Mak KM, Leo MA, Lieber CS. (1987)
Effect of ethanol and vitamin A deficiency on epithelial cell proliferation and structure in the rat esophagus.
Gastroenterology 1987,93:362-70.
Makari Y, Yasuda T, Doki Y, Miyata H, Fujiwara Y, Takiguchi S, Matsuyama J, Yamakasi M, Hirao T, Koyama MK, Nakamuara H, Monden M. (2007)
Correlation between tumor blood flow assessed by perfusion CT and effect of neoadjuvant therapy in advanced esophageal cancers.
J Surg Oncol 2007;96(3):220-229.
Malhaire JP, Labat JP, Lozac’h P, Simon H, Lucas B, Topart P, Volant A. (1996)
Preoperative concomitant radiochemotherapiy in squamous cell carcinoma of the esophagus: results of study of 56 patients.
Int J Rad Oncol Biol Phys 1996;34:429-37.
Malthaner RA., Wong RK, Rumble RB, Zuraw L., Members of the Gastro-intestinal Cancer Desease Site Group of Cancer Care Ontario’s Programme in Evidence-based Care
Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis
BMC Med 2004; 2:35.
Malthaner RA, Collin S., Fenlon D.
Preoperative chemotherapy for resectable thoracic esophageal cancer.
Cochrane Database Syst Rev 2006; issue 3. Art. No.:CD 001556
Mandard AM, Dalibard F, Mandard JC. (1994)
Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma.
Cancer 1994;73:2680-2686.
Marasas WFO, Jaskiewicz K, Venter FS, Van Schalwyk DJ. (1988)
Fusarium moniliforme contamination of maize in esophageal cancer areas in Transkei.
South Afr Med J 1988;74:110-114.
Matsumoto M, Natsugoe S, Nakashima S. (2001)
Clinical significance and prognostic value of apoptosis related proteins in superficial esophageal squamous cell carcinoma.